UBS raised the firm’s price target on Amphenol (APH) to $174 from $152 and keeps a Buy rating on the shares. The firm is relatively cautious heading into earnings, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Amphenol price target raised to $182 from $180 at Truist
- Early notable gainers among liquid option names on January 12th
- Amphenol Completes Major Acquisition of CommScope CCS Business
- Amphenol price target raised to $175 from $160 at Citi
- Amphenol upgraded to Overweight from Equal Weight at Barclays